MTZ vs OTIS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
MasTec (MTZ) presents a stark contrast between explosive growth and extreme valuation. While the Piotroski F-Score of 4/9 indicates stable financial health, the stock is trading at a massive premium, with a current price of $370.55 far exceeding both the Graham Number ($69.17) and the growth-based Intrinsic Value ($149.86). Despite strong analyst support and impressive YoY earnings growth of 92.8%, the combination of bearish insider selling, a weak technical trend (10/100), and razor-thin profit margins (2.79%) suggests significant downside risk if growth targets are missed.
OTIS presents a classic valuation-momentum conflict. While the stock trades at a significant discount to its growth-based intrinsic value ($110.92) and analyst targets ($94.36), the deterministic health is only 'Stable' with a Piotroski F-Score of 4/9. Financial health is pressured by a current ratio of 0.84 and negative book value, while aggressive insider selling and a 0/100 technical trend signal strong short-term bearishness. The company remains profitable with a healthy dividend payout, but the lack of positive price momentum and insider confidence offsets the attractive valuation.
Compare Another Pair
Related Comparisons
MTZ vs OTIS: Head-to-Head Comparison
This page compares MasTec, Inc. (MTZ) and Otis Worldwide Corporation (OTIS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.